Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2.

Source:http://linkedlifedata.com/resource/pubmed/id/20179233

Clin. Cancer Res. 2010 Mar 1 16 5 1431-41

Download in:

View as

Triples

General Info

PMID
20179233